The following material represents a subset of new drugs, drug approvals, drug warnings, and drugs removed from the market from the past six months. This isnot a complete list; it includes those topics considered by the authors and editors to be of pa...
This drug has a long half life (∼150 hours) and parasite resistance is easily induced in vitro123. Non-adherence to the recommended regimen could lead to widespread parasite resistance124. Therefore, a strictly supervised public distribution system, preferably taking the form of directly observed...
A secondary patent is a patent on aspects other than the original active drug ingredient, such as chemical variants, new formulations of the drug or methods of administration [19]. It is used to extend the effective patent life of a drug....
别催我! drug dealer 毒贩子 enough is enough! 闹够了 flyers 寻人(物)海报 get a little preoccupied 事先有事 get in line 排队(everybody get in line)大家排好队老友记中口语常用短语85个(二): get over with it 忘记 go on, i dare you! 有种你就去! go through this stack 看看这一叠 ...
NPs to be formulated using polymers, metals, nanogel and colloidal systems, or vesicular systems as liposomes organized from double-chain phospholipids, ethosomes, transfersomes, and bilosomes, or niosomes for efficient drug delivery to the brain [129]. Niosomes are composed of cholesterol or ...
Another common adjustment is add-on therapy to the existing regimen. This is often done without regard to the mode of action(s) that align with one of the drivers of hyperglycemia in a given patient. Ineffective therapy is costly in terms of drug acquisition cost as well as the potential ...
Jang S, Atkins MB: Which drug, and when, for patients with BRAF-mutant melanoma?. Lancet Oncol. 2013, 14: e60-e69. 10.1016/S1470-2045(12)70539-9. Article CAS PubMed Google Scholar Grimaldi AM, Simeone E, Giannarelli D, Muto P, Falivene S, Borzillo V, Giugliano FM, Sandomenico ...
Pain is one of the most common reasons for an individual to consult their primary care physician1–3, with one in five adults in Europe estimated to be affected by chronic pain4. However, one of the...
Because of its potency, recombinant soluble CR1 has been considered as a complement-inhibiting drug[48, 70]. In the central nervous system, administration of sCR1 in rats resulted in a 40% decrease in brain neutrophil accumulation in the traumatized hemisphere as compared to normal controls[52,...
Recent Pat Inflamm Allergy Drug Discov. 2007;1(1):1–8. CAS PubMed Google Scholar Karagiannidis C, Hense G, Martin C, Epstein M, Ruckert B, Mantel PY, et al. Activin A is an acute allergen-responsive cytokine and provides a link to TGF-beta-mediated airway remodeling in asthma. J...